Section Arrow
Quote
COEP.NASDAQ
- Coeptis Therapeutics Holdings Inc
Quotes are at least 15-min delayed:2026/04/22 02:18 EDT
Regular Hours
Last
 14.93
-0.61 (-3.93%)
Day High 
16.1 
Prev. Close
15.54 
1-M High
16 
Volume 
107.63K 
Bid
14.99
Ask
15.6
Day Low
14.75 
Open
15.91 
1-M Low
9.78 
Market Cap 
96.71M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.73 
20-SMA 11.92 
50-SMA 11.96 
52-W High 21.41 
52-W Low 6.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.81/-0.29
Enterprise Value
96.86M
Balance Sheet
Book Value Per Share
2.18
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.36M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1968-0.0651-24.86%-- 
XRTXXORTX Therapeutics Inc.2.69+0.44+19.56%-- 
TOVXTheriva Biologics Inc0.3387-0.0713-17.39%0.09PE
GERNGeron Corp1.5-0.06-3.85%-- 
SPRCSciSparc Ltd.5.99+1.76+41.61%0PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatmentparadigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.